18F-胆碱PET/CT影像组学预测高危前列腺癌疾病结局:94例患者机器学习特征分类的探索性研究
本研究纳入94例高危前列腺癌再分期患者,提取胆碱PET/CT病灶的51个纹理特征,用判别分析构建机器学习模型预测随访疾病进展。全组2个特征判别进展的敏感度47.1%、特异度76.5%、准确率67.6%;T、N、M亚组分别以3个、2个、2个特征获得较好分类性能。
要点
- 全组仅HISTO_Entropy_log10与HISTO_Energy_Uniformity两特征判别进展,敏感度47.1%、特异度76.5%。
- T亚组以SUVmin、SHAPE_Sphericity、GLCM_Correlation三特征分类,敏感度91.6%、特异度84.1%。
- N亚组以HISTO_Energy_Uniformity与GLZLM_SZLGE两特征分类,敏感度68.1%、特异度91.4%。
关键影像表现/征象
- 全组判别疾病进展采用HISTO_Entropy_log10与HISTO_Energy_Uniformity两个特征。
- T亚组(原发灶或局部复发)采用SUVmin、SHAPE_Sphericity、GLCM_Correlation三个特征。
- N亚组(淋巴结病变)采用HISTO_Energy_Uniformity与GLZLM_SZLGE两个特征。
- M亚组(转移性病变)采用HISTO_Entropy_log10与HISTO_Entropy_log2两个特征。
诊断标准与关键数值
- 全组:敏感度47.1%、特异度76.5%、阳性预测值46.7%、准确率67.6%。
- T亚组:敏感度91.6%、特异度84.1%、阳性预测值79.1%、准确率87%。
- N亚组:敏感度68.1%、特异度91.4%、阳性预测值83%、准确率82.6%。
- M亚组:敏感度64.4%、特异度74.6%、阳性预测值40.6%、准确率72.5%。
临床应用与阅片要点
- 作者认为该机器学习模型可行且有助于筛选胆碱PET特征并与高危前列腺癌患者结局相关。
- 作者指出需进一步前瞻性研究确认结果并推动人工智能在前列腺癌PET成像中的应用。
局限性
- 作者指出需进一步前瞻性研究确认结果并推动人工智能在前列腺癌PET成像中的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was (1) to investigate the application of texture analysis of choline PET/CT images in prostate cancer (PCa) patients and (2) to propose a machine-learning radiomics model able to select PET features predictive of disease progression in PCa patients with a same high-risk class at restaging.
MATERIAL AND METHODS: Ninety-four high-risk PCa patients who underwent restaging Cho-PET/CT were analyzed. Follow-up data were recorded for a minimum of 13 months after the PET/CT scan. PET images were imported in LIFEx toolbox to extract 51 features from each lesion. A statistical system based on correlation matrix and point-biserial-correlation coefficient has been implemented for features reduction and selection, while Discriminant analysis (DA) was used as a method for features classification in a whole sample and sub-groups for primary tumor or local relapse (T), nodal disease (N), and metastatic disease (M).
RESULTS: In the whole group, 2 feature (HISTO_Entropy_log10; HISTO_Energy_Uniformity) results were able to discriminate the occurrence of disease progression at follow-up, obtaining the best performance in DA classification (sensitivity 47.1%, specificity 76.5%, positive predictive value (PPV) 46.7%, and accuracy 67.6%). In the sub-group analysis, the best performance in DA classification for T was obtained by selecting 3 features (SUVmin; SHAPE_Sphericity; GLCM_Correlation) with a sensitivity of 91.6%, specificity 84.1%, PPV 79.1%, and accuracy 87%; for N by selecting 2 features (HISTO = _Energy Uniformity; GLZLM_SZLGE) with a sensitivity of 68.1%, specificity 91.4%, PPV 83%, and accuracy 82.6%; and for M by selecting 2 features (HISTO_Entropy_log10 - HISTO_Entropy_log2) with a sensitivity 64.4%, specificity 74.6%, PPV 40.6%, and accuracy 72.5%.
CONCLUSION: This machine learning model demonstrated to be feasible and useful to select Cho-PET features for T, N, and M with valuable association with high-risk PCa patients' outcomes.
KEY POINTS: • Artificial intelligence applications are feasible and useful to select Cho-PET features. • Our model demonstrated the presence of specific features for T, N, and M with valuable association with high-risk PCa patients' outcomes. • Further prospective studies are necessary to confirm our results and to develop the application of artificial intelligence in PET imaging of PCa.
引用
- Alongi P, Stefano A, Comelli A, et al. Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients. Eur Radiol. 2021. PMID: 33443602. doi:10.1007/s00330-020-07617-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。